In-vitro and In-vivo Evaluation of Silymarin Nanoliposomes against Isolated Methicillin-resistant Staphylococcus aureus

Authors

  • Amir Gharib Department of Laboratory Sciences, Borujerd Branch, Islamic Azad University, Borujerd, Iran
  • Masoud Godarzee Department of Biology, Borujerd Branch, Islamic Azad University, Borujerd, Iran
  • Zohreh Faezizadeh Department of Laboratory Sciences, Borujerd Branch, Islamic Azad University, Borujerd, Iran
Abstract:

Staphylococcus aureus is an opportunistic pathogen and remains a common cause of burn wound infections. Different studies have shown that entrapment of plant-derived compounds into liposomes could increase their anti-Staphylococcus aureus activity. Silymarin is the bioactive extract from the known plant Silybum marianum L. The objective of this study was to evaluate efficacy of silymarin in free and nanoliposomal forms against isolated methicillin-resistant Staphylococcus aureus (MRSA) strain. Silymarin-loaded nanoliposomes were prepared by extrusion method. The minimum inhibitory concentrations (MICs) of silymarin in free and nanoliposomal forms against MRSA were determined by broth dilution method. The killing rate of free and nanoliposomal forms of silymarin were analyzed. Ultimately, in vivo therapeutic efficacy of nanoliposomes in burned mice infected by isolated MRSA was examined. The MICs of free and nanoliposomal forms of silymarin against isolated strain were 500 and 125 mg/l, respectively. The killing rate of silymarin-loaded nanoliposomes was higher than those of free silymarin. Topically treatment by silymarin in free and nanoliposomal forms resulted in almost 20 and 100% survival rates, respectively. The results suggest that silymarin-loaded nanoliposomes may provide a basis for future treatment of MRSA infections.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

In-vitro and In-vivo Evaluation of Silymarin Nanoliposomes against Isolated Methicillin-resistant Staphylococcus aureus

Staphylococcus aureus is an opportunistic pathogen and remains a common cause of burn wound infections. Different studies have shown that entrapment of plant-derived compounds into liposomes could increase their anti-Staphylococcus aureus activity. Silymarin is the bioactive extract from the known plant Silybum marianum L. The objective of this study was to evaluate efficacy of silymarin in fre...

full text

in-vitro and in-vivo evaluation of silymarin nanoliposomes against isolated methicillin-resistant staphylococcus aureus

staphylococcus aureus is an opportunistic pathogen and remains a common cause of burn wound infections. different studies have shown that entrapment of plant-derived compounds into liposomes could increase their anti-staphylococcus aureus activity. silymarin is the bioactive extract from the known plant silybum marianum l. the objective of this study was to evaluate efficacy of silymarin in fre...

full text

In vitro susceptibility of chloramphenicol against methicillin-resistant Staphylococcus aureus.

OBJECTIVE To determine the in vitro susceptibility of chloramphenicol against methicillin-resistant Staphylococcus aureus. STUDY DESIGN Cross-sectional study. PLACE AND DURATION OF STUDY Department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi, from January to June 2012. METHODOLOGY One hundred and seventy four isolates of methicillin-resistant Staphylococcus aureus wer...

full text

Effects of short interfering RNA against methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo.

OBJECTIVES The emergence of antibiotic-resistant bacteria such as Staphylococcus aureus calls for inventive research and development strategies. Inhibition of bacterial pathogenesis may be a promising therapeutic approach in this regard. The gene-silencing effect of short interfering RNA (siRNA) is useful for this strategy. We investigated the efficacy of siRNA on the expression of coagulase be...

full text

Prevalence of Vancomycin Resistance in Methicillin-Resistant Staphylococcus Aureus

Background & Aims: Staphylococcus aureus is one of the most common pathogens in nosocomial infections. Vancomycin is the most important therapeutic drug of choice for treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA) strains. Therefore, vancomycin-resistant Staphylococcus aureus (VRSA) or vancomycin-intermediate Staphylococcus aureus (VISA) strains are warning...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 14  issue 2

pages  627- 633

publication date 2015-05-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023